Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.
| Revenue (Most Recent Fiscal Year) | $54.72M |
| Net Income (Most Recent Fiscal Year) | $5.15M |
| PE Ratio (Current Year Earnings Estimate) | 25.20 |
| PE Ratio (Trailing 12 Months) | 25.83 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.79 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.97 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 29.49 |
| Pre-Tax Margin (Trailing 12 Months) | 15.64% |
| Net Margin (Trailing 12 Months) | 11.65% |
| Return on Equity (Trailing 12 Months) | 16.41% |
| Return on Assets (Trailing 12 Months) | 13.92% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.19 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.84 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 3.99 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.24 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.21 |
| Earnings per Share (Most Recent Fiscal Year) | $0.58 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.79 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 8.39M |
| Free Float | 7.21M |
| Market Capitalization | $171.16M |
| Average Volume (Last 20 Days) | 0.08M |
| Beta (Past 60 Months) | 0.46 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 14.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 40.82% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |